Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
Rischin
Danny
D
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Danny.Rischin@petermac.org
Fisher
Richard
R
Peters
Lester
L
Corry
June
J
Hicks
Rodney
R
D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000556:secondary; D015687:Cell Hypoxia; D002945:Cisplatin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D006801:Humans; D049268:Positron-Emission Tomography; D011379:Prognosis; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D000077704:Tirapazamine; D014227:Triazines / Q000627:therapeutic use
D011838:Radiation-Sensitizing Agents; D014227:Triazines; D000077704:Tirapazamine; D002945:Cisplatin